The news media is the main decline for this stock, which equals buy. The Vitorin press did not say the drug was bad, it said it may not do all the things advertised. So, listening to the conference calls, the execs are firm in their belief the drug will be redeemed. Until then, look at all the different businesses SGP is in: Claratin, Dr. Sholls,... More importantly than any of it, look at their pipeline of drugs submitted for approval. No other drug company is that loaded, and isn't that what Pharma company stocks trade on anyway? Like my buddies in REO Speedwagon, I'm "riding the storm out" and going long with Schering-Plough.
--Brad
Oh, they're pretty good on cash too. So they have that going for them.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment